Results 131 to 140 of about 31,414 (269)

Jefferson Digital Commons quarterly report: January-March 2020 [PDF]

open access: yes, 2020
This quarterly report includes: New Look for the Jefferson Digital Commons Articles COVID-19 Working Papers Educational Materials From the Archives Grand Rounds and Lectures JeffMD Scholarly Inquiry Abstracts Journals and Newsletters Master of Public ...
Copeland, LIBT, James   +2 more
core   +1 more source

Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol [PDF]

open access: yes, 2017
Introduction: Fatigue is a frequent and troublesome manifestation of chronic sarcoidosis. This symptom can be debilitating and difficult to treat, with poor response to the treatment.
Atkins, Christopher   +5 more
core   +1 more source

Risk of Adverse Outcomes Associated With Cardiac Sarcoidosis Diagnostic Schemes

open access: bronze, 2023
Rahul Myadam   +30 more
openalex   +2 more sources

Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy [PDF]

open access: yes, 2019
BackgroundPulmonary hypertension (PH) is a known complication of HCM and is a strong predictor of mortality. We aim to investigate the relationship between microvascular dysfunction measured by quantitative PET and PH in HCM patients.MethodsEighty-nine ...
Leal, Jeffrey P   +6 more
core   +3 more sources

A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology [PDF]

open access: bronze, 2017
Riemer H. J. A. Slart   +15 more
openalex   +1 more source

Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis

open access: yesEJNMMI Research, 2017
Background Cardiac sarcoidosis is associated with major adverse cardiac events including cardiac arrest, for which anti-inflammatory treatment is indicated. Oral corticosteroid is the mainstay among treatment options; however, adverse effects are a major
Mitsutomi Ishiyama   +2 more
doaj   +1 more source

Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis

open access: yesJournal of Nuclear Cardiology, 2023
R. Vis   +7 more
semanticscholar   +1 more source

Genetic Cardiomyopathy Masquerading as Cardiac Sarcoidosis.

open access: yesJournal of the American College of Cardiology, 2023
Mallika Lal   +6 more
semanticscholar   +1 more source

Sarcoidosis: comprehensive CMR evaluation and major adverse cardiac events [PDF]

open access: gold, 2016
Angela Higgins   +3 more
openalex   +1 more source

Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis

open access: diamond, 2022
Kenji Yodogawa   +12 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy